Home/Filings/4/0001104659-20-080541
4//SEC Filing

Schranz Jennifer 4

Accession 0001104659-20-080541

CIK 0001641640other

Filed

Jul 1, 8:00 PM ET

Accepted

Jul 2, 4:07 PM ET

Size

4.5 KB

Accession

0001104659-20-080541

Insider Transaction Report

Form 4
Period: 2020-06-30
Schranz Jennifer
Chief Medical Officer
Transactions
  • Tax Payment

    Ordinary Shares

    2020-06-30$0.67/sh301$203168,745 total

Documents

1 file

Issuer

Nabriva Therapeutics plc

CIK 0001641640

Entity typeother

Related Parties

1
  • filerCIK 0001735382

Filing Metadata

Form type
4
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 4:07 PM ET
Size
4.5 KB